Company intelligence / Profile preview

SEUM IP

Ownership: Private
Development stage: Other

Overview

SEUM IP is an intellectual property and patent law firm specializing in building strategic patent portfolios for clients in various technology sectors. The firm's expertise includes biotechnology, pharmaceutics, cosmetics, food technology, and chemistry. Its professionals have experience prosecuting patents related to small molecules, antibodies, proteins, peptides, oncolytic viruses, immune cells, stem cells, genome editing technologies (such as CRISPR), and vaccines. However, SEUM IP does not develop drugs or therapeutics itself.

Industry: Consulting

Beyond the preview

Go deeper on SEUM IP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEUM IP.

Explore the full profile